These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 16257524)

  • 1. Skin biopsies for the measurement of clinical pharmacodynamic biomarkers.
    Phillips RL; Sachs AB
    Curr Opin Biotechnol; 2005 Dec; 16(6):687-90. PubMed ID: 16257524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation: planning for a source of pharmacokinetic/pharmacodynamic variability in translational studies.
    Schmith VD; Foss JF
    Clin Pharmacol Ther; 2010 Apr; 87(4):488-91. PubMed ID: 20147898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of compound mode of action by computational integration of whole-genome measurements and genetic perturbations.
    Hallén K; Björkegren J; Tegnér J
    BMC Bioinformatics; 2006 Feb; 7():51. PubMed ID: 16451737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Innovation and greater probability of success in drug discovery and development -- from target to biomarkers.
    Kola I; Hazuda D
    Curr Opin Biotechnol; 2005 Dec; 16(6):644-6. PubMed ID: 16263257
    [No Abstract]   [Full Text] [Related]  

  • 5. Exploiting naturally occurring DNA variation and molecular profiling data to dissect disease and drug response traits.
    Schadt EE
    Curr Opin Biotechnol; 2005 Dec; 16(6):647-54. PubMed ID: 16249078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular imaging strategies for drug discovery and development.
    Gross S; Piwnica-Worms D
    Curr Opin Chem Biol; 2006 Aug; 10(4):334-42. PubMed ID: 16822702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combinatorial biomarkers: From early toxicology assays to patient population profiling.
    Koop R
    Drug Discov Today; 2005 Jun; 10(11):781-8. PubMed ID: 15922936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Less is more: the human microdosing concept.
    Garner RC
    Drug Discov Today; 2005 Apr; 10(7):449-51. PubMed ID: 15809185
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical trials in dermatology. The phase I trials].
    Czernielewski J; Queille-Roussel C; Duteil L; Verschoore M; Schaefer H; Revuz J; De Prost Y; Guillaume JC; Ortonne JP
    Therapie; 1991; 46(3):183-7. PubMed ID: 1792649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors determining the optimal body site and method for obtaining punch biopsies of human skin as a tissue in which to assess pharmacodynamic and pharmacokinetic endpoints in drug development studies.
    Camidge DR; Davies MJ; Laud PJ; Marshall AL; Cockerill M; Smith PD; Hughes AM
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):52-8. PubMed ID: 16032432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Getting the dose right": facts, a blueprint, and encouragements.
    Peck CC; Cross JT
    Clin Pharmacol Ther; 2007 Jul; 82(1):12-4. PubMed ID: 17571068
    [No Abstract]   [Full Text] [Related]  

  • 13. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
    Yao Y; Richman L; Higgs BW; Morehouse CA; de los Reyes M; Brohawn P; Zhang J; White B; Coyle AJ; Kiener PA; Jallal B
    Arthritis Rheum; 2009 Jun; 60(6):1785-96. PubMed ID: 19479852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative pharmacology or pharmacokinetic pharmacodynamic integration should be a vital component in integrative pharmacology.
    Gabrielsson J; Green AR
    J Pharmacol Exp Ther; 2009 Dec; 331(3):767-74. PubMed ID: 19779129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism and pharmacokinetics in children and the elderly.
    Pelkonen O
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):147-8. PubMed ID: 17428146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in paediatric pharmacokinetics.
    Knibbe CA; Krekels EH; Danhof M
    Expert Opin Drug Metab Toxicol; 2011 Jan; 7(1):1-8. PubMed ID: 21117982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vesicles as tools for the modulation of skin permeability.
    Dubey V; Mishra D; Nahar M; Jain NK
    Expert Opin Drug Deliv; 2007 Nov; 4(6):579-93. PubMed ID: 17970662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of pharmacodynamic research in the assessment and development of new antibacterial drugs.
    Lister PD
    Biochem Pharmacol; 2006 Mar; 71(7):1057-65. PubMed ID: 16316633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biotransformation of drugs in human skin.
    Svensson CK
    Drug Metab Dispos; 2009 Feb; 37(2):247-53. PubMed ID: 19005027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the molecular profile of basal cell carcinoma using whole genome microarrays.
    O'Driscoll L; McMorrow J; Doolan P; McKiernan E; Mehta JP; Ryan E; Gammell P; Joyce H; O'Donovan N; Walsh N; Clynes M
    Mol Cancer; 2006 Dec; 5():74. PubMed ID: 17173689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.